World

EU drug regulator: Uncommon blood clot is ‘very uncommon AstraZeneca aspect impact’



The EU’s medicines regulator finds the advantages of the Covid-19 vaccine outweigh the dangers.



Supply hyperlink

Related Articles

Back to top button